Surface plasmon resonance biosensor for measurement of anti-glycolipid antibody levels in neuropathy
US7074621B2 · kind B2 · utility
7Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2004 |
| Grant date | Jul 11, 2006 |
| Priority date | — |
| Expiry date | Jul 26, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/805
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides a method of detecting human antibodies in a sera solution. The invention also provides a method of quantitating anti-glycolipid antibody levels in solutions. The invention provides a method of diagnosing disease states, including neurological diseases, by quantitating a subject's antibody levels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.